Related Experiment Video
Updated: Jan 14, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.7K
A multi-view multimodal deep learning framework for Alzheimer's disease diagnosis.
Jianxin Feng1,2, Xinyu Zhao1,2, Zhiguo Liu1,2
1Communication and Network Key Laboratory, Dalian University, Dalian, China.
Frontiers in Neuroscience
|October 17, 2025
Summary
A new framework, ADMV-Net, improves Alzheimer's disease diagnosis by fusing multimodal neuroimaging data. This AI tool enhances accuracy in distinguishing Alzheimer's disease from normal cognition, aiding early detection.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Early Alzheimer's disease (AD) diagnosis is challenging due to similarities with mild cognitive impairment (MCI) and cognitively normal (CN) individuals.
- Population heterogeneity, label noise, and imaging variations further complicate diagnosis.
- Current multimodal neuroimaging approaches have limitations in fusing complementary data and aggregating multi-scale features.
Purpose of the Study:
- To develop a novel multimodal diagnostic framework, ADMV-Net, for enhanced recognition accuracy across all Alzheimer's disease stages.
- To improve the fusion of multimodal neuroimaging data and multi-scale feature extraction for more robust AD diagnosis.
Main Methods:
- Proposed ADMV-Net framework utilizes a dual-pathway Hybrid Convolution ResNet for 3D medical image feature extraction, fusing global and local information.
- Implemented a Multi-view Fusion Learning mechanism with Global Perception, Multi-level Local Cross-modal Aggregation, and Bidirectional Cross-Attention modules.
- Incorporated a Regional Interest Perception Module to focus on AD-pathology-associated brain regions.
Main Results:
- ADMV-Net achieved 94.83% accuracy and 95.97% AUC in distinguishing Alzheimer's disease (AD) from cognitively normal (CN) individuals.
- The framework demonstrated superior performance compared to mainstream methods in AD vs. CN classification.
- Showcased strong discriminative capability and excellent generalization in multi-class classification tasks.
Conclusions:
- ADMV-Net effectively leverages multimodal and multi-view information to significantly improve Alzheimer's disease diagnostic accuracy.
- The framework's integration of global, local, and regional features offers a promising tool for early AD diagnosis and clinical decision-making.
- The developed framework provides a valuable resource for advancing Alzheimer's disease research and clinical practice.
Related Concept Videos
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
